Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:2
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 1
2 (50.0%)A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Gastrointestinal DiscomfortPerformance Status
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05296083
- Locations
- 🇳🇱
EB FlevoResearch, Almere, Flevoland, Netherlands
A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure
Phase 1
Completed
- Conditions
- Heart Failure
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2021-11-26
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04846816
- Locations
- 🇬🇧
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device)
Not Applicable
Completed
- Conditions
- Healthy Volunteer Study
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04836572
- Locations
- 🇺🇸
Community Clinical Research Network, Marlborough, Massachusetts, United States
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
Phase 1
Completed
- Conditions
- Heart Failure
- Interventions
- Device: Medfusion 3500 (v6) precision infusion pump
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- SQ Innovation, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04384653
- Locations
- 🇺🇸
Accel Research Sites - DeLand Clinical Research Unit, DeLand, Florida, United States
News
No news found